Through a genome-wide CRISPR/Cas9 screen in MLL-AF9 primary murine cells, DCPS, a mRNA 5′ cap binding enzyme shown to have a role in mRNA decay, was identified to be significantly depleted and critical for AML survival [84]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.